Singapore #9107 (v.1)
Base data
- Notified in
-
G/MA/QR/N/SGP/6 06/11/2024
- Version validity
-
11/04/2023 -
01/09/2024
Old version v.1
- Reporting member
- Singapore
- In force from
- End date
- In force
- General description
-
Non-automatic licence for the import of Chinese proprietary medicines (CPMs)
- National legal basis
-
Medicines Act, 1975
- Administrative mechanism
-
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016, CPMs will continue to be regulated under the Medicines Act for now.
More information can be found at: https://www.hsa.gov.sg/.
Administered by HSA.
- Responsible entities
-
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Reported as: Article XX(b) of the GATT - Non-WTO commitments
-
- Affected partners
- Non-affected partners
Measures
- Reported restrictions
- NAL
| Symbol |
|---|
|
NAL
|
Tariff lines
|
12
|
Chapter 12
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|
|
13
|
Chapter 13
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|
|
30
|
Chapter 30
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|